Capstone Investment Advisors, LLC Charles River Laboratories International, Inc. Call Options Transaction History

Capstone Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $18,796 - $24,529	-100 Reduced 33.33%	200 $39,000
Q1 2024 May 01, 2024	SELL	$203.52 - $273.43 $20,352 - $27,343	-100 Reduced 25.0%	300 $81,000
Q4 2023 Feb 12, 2024	BUY	$164.52 - $238.84 $65,808 - $95,536	400 New	400 $94,000
Q1 2023 May 09, 2023	BUY	$191.89 - $259.92 $95,945 - $129,960	500 New	500 $100,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $20,413 - $30,239	-100 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $351,380 - $448,680	-1,000 Reduced 90.91%	100 $38,000
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $260,848 - $320,810	700 Added 175.0%	1,100 $453,000
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $117,668 - $148,660	400 New	400 $147,000

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.48B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.